SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-138304
Filing Date
2014-04-10
Accepted
2014-04-10 13:09:00
Documents
2
Group Members
ANSBERT GADICKEJAMES PAUL SCOPALUKE EVNINMEDICAL PORTFOLIO MANAGEMENT LLCMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCMPM CAPITAL LLCTODD FOLEYVAUGHN M. KAILIAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d710790dsc13da.htm SC 13D/A 225611
2 EX-A d710790dex99a.htm EX-99.A 18233
  Complete submission text file 0001193125-14-138304.txt   245743
Mailing Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 (617) 425-9200
MPM BIOVENTURES V, L.P. (Filed by) CIK: 0001482716 (see all company filings)

IRS No.: 270793842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87524 | Film No.: 14756104
SIC: 2834 Pharmaceutical Preparations